The Eighth edition of Indian Pharmacopoeia (IP-2018) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health and Family Welfare, Government of India in fulfillment of the requirements of the Drugs and Cosmetic Act, 1940 and the Rules there under.

IP-2018 has been brought out in 4 Volumes incorporating 220 new monographs (Chemical Monographs (170), Herbal Monographs (15), Blood and Blood related products (10), Vaccines and Immunosera for Human use monographs (02), Radiopharmaceutical monographs (03), Biotechnology Derived Therapeutic Products (06), Veterinary monographs (14), 366 revised monographs and 7 omissions. Standards for new drugs and drugs used under National Health Programmes are also included. 53 New Fixed Dose Combination (FDC’s) combination monographs have been included, out of which 25 FDC monographs are not available in any Pharmacopoeia.

Indian Pharmacopoeia 2018 Salient Features:

New Monographs : 220

Revisions : 366

Omissions : 07

170 New Chemical Monographs :

49 API

64 Formulations

53 Fixed Dose Formulations

02 Excipients

02 Antibiotics

15 New Herbs and Herbal Products Monographs

03 New Radiopharmaceutical Monographs

14 New Veterinary Non-Biological Monographs

18 New Biological Monographs :

02 Vaccines & Immunosera for Human Use

06 Biotechnology Derived Therapeutic Products

10 Blood and Blood Related Products

Standards for New Drugs, Drugs under National Health Programme & Drugs in National List of Essential Medicines have been included

For ease of access and to make Pharmacopoeia more user friendly index has been incorporated in Volume 1 along with that already existing in Volume IV of IP